{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:22:49Z","timestamp":1793506969162,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014369","name":"Organon BioSciences","doi-asserted-by":"publisher","award":["59607"],"award-info":[{"award-number":["59607"]}],"id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Individuals with substance use disorders (SUD) have disproportionately high rates of unintended pregnancy. Reducing harm associated with this risk and its biopsychosocial consequences requires evidence-based, non-coercive interventions that ensure access to contraception for individuals who choose to prevent pregnancy. We examined feasibility and impact of SexHealth Mobile, a mobile unit-based intervention that aimed to increase access to patient-centered contraceptive care for individuals in SUD recovery programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a quasi-experimental study (enhanced usual care [EUC] followed by intervention) at three recovery centers with participants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200998) at risk for unintended pregnancy. EUC participants were offered printed information on community locations where they could access contraception care. SexHealth Mobile participants were offered same-day, onsite clinical consultation on a medical mobile unit and contraception if desired. The primary outcome was use of contraception (hormonal or intrauterine device) at one-month post-enrollment. Secondary outcomes were at two-weeks and three-months. Confidence in preventing unintended pregnancy, reasons for non-use of contraception at follow-up, and intervention feasibility were also assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants (median age\u2009=\u200931, range 19\u201340) enrolled in the intervention period\u00a0were almost 10 times more likely to be using contraception at one-month (51.5%) versus the those enrolled in the EUC period (5.4%) (unadjusted relative risk [URR]\u2009=\u20099.3 [95%CI: 2.3\u201337.1]; adjusted relative risk [ARR]\u2009=\u20099.8 [95%CI: 2.4\u201339.2]). Intervention participants were also more likely to be using contraception at 2-weeks (38.7% vs. 2.6%; URR\u2009=\u200914.3 [95%CI: 2.0\u2013104.1]) and three-months (40.9% vs. 13.9%; URR\u2009=\u20092.9 [95% CI: 1.1\u20137.4]). EUC participants reported more barriers (cost, time) and less confidence in preventing unintended pregnancies. Mixed-methods feasibility data indicated high acceptability and feasible integration into recovery settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mobile contraceptive care based on principles of reproductive justice and harm reduction reduces access barriers, is feasible to implement in SUD recovery settings, and increases contraception use.\u202fExpanding interventions like SexHealth Mobile may help reduce harm from unintended pregnancies among individuals in SUD recovery.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial Registration<\/jats:italic>\n                      NCT04227145.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-023-00760-7","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T01:02:34Z","timestamp":1678064554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study"],"prefix":"10.1186","volume":"20","author":[{"given":"Emily A.","family":"Hurley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Goggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Pi\u00f1a-Brugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle R.","family":"Noel-MacDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Finocchario-Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"760_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000886","author":"S Shafique","year":"2021","unstructured":"Shafique S, Umer A, Innes KE, Rudisill TM, Fang W, Cottrell L. Preconception substance use and risk of unintended pregnancy: pregnancy risk assessment monitoring system 2016\u201317. J Addict Med. 2021. https:\/\/doi.org\/10.1097\/ADM.0000000000000886.","journal-title":"J Addict Med."},{"issue":"2","key":"760_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CCM.0b013e31823e986a.A","volume":"40","author":"SH Heil","year":"2011","unstructured":"Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abus Treat. 2011;40(2):199\u2013202. https:\/\/doi.org\/10.1097\/CCM.0b013e31823e986a.A.","journal-title":"J Subst Abus Treat"},{"issue":"31","key":"760_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","volume":"67","author":"SC Haight","year":"2018","unstructured":"Haight SC, Ko JY, Van Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014. Morb Mortal Wkly Rep. 2018;67(31):845\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6731a1.","journal-title":"Morb Mortal Wkly Rep"},{"key":"760_CR4","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304771","author":"LK Admon","year":"2019","unstructured":"Admon LK, Bart G, Kozhimannil KB, Richardson CR, Dalton VK, Winkelman TNA. Amphetamine-And opioid-affected births: incidence, outcomes, and costs, United States 2004\u20132015. Am J Public Health. 2019. https:\/\/doi.org\/10.2105\/AJPH.2018.304771.","journal-title":"Am J Public Health."},{"key":"760_CR5","doi-asserted-by":"publisher","unstructured":"Czeisler M\u00c9, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic\u2014United States, June 24\u201330, 2020. MMWR Morb Mortal Wkly Rep. 2020. https:\/\/doi.org\/10.15585\/mmwr.mm6932a1","DOI":"10.15585\/mmwr.mm6932a1"},{"key":"760_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2019.1656255","author":"LK MacAfee","year":"2020","unstructured":"MacAfee LK, Harfmann RF, Cannon LM, et al. Substance use treatment patient and provider perspectives on accessing sexual and reproductive health services: barriers, facilitators, and the need for integration of care. Subst Use Misuse. 2020. https:\/\/doi.org\/10.1080\/10826084.2019.1656255.","journal-title":"Subst Use Misuse"},{"key":"760_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-018-0056-y","author":"RL Fischbein","year":"2018","unstructured":"Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018. https:\/\/doi.org\/10.1186\/s40834-018-0056-y.","journal-title":"Contracept Reprod Med"},{"key":"760_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00532-1","author":"SL Stancil","year":"2021","unstructured":"Stancil SL, Miller MK, Duello A, et al. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00532-1.","journal-title":"Harm Reduct J"},{"issue":"8","key":"760_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0890117120927327","volume":"34","author":"EA Hurley","year":"2020","unstructured":"Hurley EA, Duello A, Finocchario-Kessler S, et al. Expanding contraception access for women with opioid-use disorder: a qualitative study of opportunities and challenges. Am J Heal Promot. 2020;34(8):909\u201318.","journal-title":"Am J Heal Promot"},{"issue":"5","key":"760_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1473325013498110","volume":"13","author":"K Drescher-Burke","year":"2014","unstructured":"Drescher-Burke K. Contraceptive risk-taking among substance-using women. Qual Soc Work. 2014;13(5):636\u201353. https:\/\/doi.org\/10.1177\/1473325013498110.","journal-title":"Qual Soc Work"},{"key":"760_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/J.WHI.2022.06.003","author":"M McCartin","year":"2022","unstructured":"McCartin M, Cannon LM, Harfmann RF, Dalton VK, MacAfee LK, Kusunoki Y. Stigma and reproductive health service access among women in treatment for substance use disorder. Women\u2019s Heal Issues. 2022. https:\/\/doi.org\/10.1016\/J.WHI.2022.06.003.","journal-title":"Women\u2019s Heal Issues"},{"key":"760_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2014.08.012","author":"S Lamy","year":"2015","unstructured":"Lamy S, Laqueille X, Thibaut F. Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: a review. Encephale. 2015. https:\/\/doi.org\/10.1016\/j.encep.2014.08.012.","journal-title":"Encephale"},{"key":"760_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/add.15509","author":"FA Perez","year":"2022","unstructured":"Perez FA, Blythe S, Wouldes T, McNamara K, Black KI, Oei JL. Prenatal methamphetamine\u2014impact on the mother and child\u2014a review. Addiction. 2022. https:\/\/doi.org\/10.1111\/add.15509.","journal-title":"Addiction"},{"issue":"2","key":"760_CR14","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"KP Neonatal","year":"2014","unstructured":"Neonatal KP, Syndrome A. Pediatrics. 2014;134(2):e547\u201361. https:\/\/doi.org\/10.1542\/peds.2013-3524.","journal-title":"Pediatrics"},{"issue":"6","key":"760_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jogn.2017.08.006","volume":"46","author":"LF Scott","year":"2017","unstructured":"Scott LF, Shieh C, Umoren RA, Conard T. Care Experiences of Women Who Used Opioids and Experienced Fetal or Infant Loss. JOGNN - J Obstet Gynecol Neonatal Nurs. 2017;46(6):846\u201356. https:\/\/doi.org\/10.1016\/j.jogn.2017.08.006.","journal-title":"JOGNN - J Obstet Gynecol Neonatal Nurs"},{"key":"760_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-14-5","author":"A Olsen","year":"2014","unstructured":"Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. BMC Womens Health. 2014. https:\/\/doi.org\/10.1186\/1472-6874-14-5.","journal-title":"BMC Womens Health"},{"key":"760_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108378","author":"EA Hurley","year":"2021","unstructured":"Hurley EA, Pi\u00f1a K, Cegielski V, Noel-MacDonnell JR, Miller MK. Recovering from substance use disorders during the early months of the COVID-19 pandemic: A mixed-methods longitudinal study of women in Kansas City. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2021.108378.","journal-title":"J Subst Abuse Treat."},{"key":"760_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.13.1689","author":"AT McLellan","year":"2000","unstructured":"McLellan AT, Lewis DC, O\u2019Brien CP, Kleber HD. Drug dependence, a chronic medical illness implications for treatment, insurance, and outcomes evaluation. J Am Med Assoc. 2000. https:\/\/doi.org\/10.1001\/jama.284.13.1689.","journal-title":"J Am Med Assoc"},{"key":"760_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105794","author":"SH Heil","year":"2019","unstructured":"Heil SH, Melbostad HS, Rey CN. Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids. Prev Med. 2019. https:\/\/doi.org\/10.1016\/j.ypmed.2019.105794.","journal-title":"Prev Med"},{"issue":"S5","key":"760_CR20","doi-asserted-by":"publisher","first-page":"S494","DOI":"10.2105\/AJPH.2022.306915","volume":"112","author":"DS Cadena","year":"2022","unstructured":"Cadena DS, Chaudhri A, Scott C. Contraceptive care using reproductive justice principles: beyond access. Am J Public Health. 2022;112(S5):S494\u20139. https:\/\/doi.org\/10.2105\/AJPH.2022.306915.","journal-title":"Am J Public Health"},{"issue":"6","key":"760_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1360-0443.2011.03699.x","volume":"107","author":"JC Lucke","year":"2012","unstructured":"Lucke JC, Hall WD. Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction. 2012;107(6):1036\u201341. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03699.x.","journal-title":"Addiction"},{"issue":"10","key":"760_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamapsychiatry.2021.1284","volume":"78","author":"AD Lyerly","year":"2021","unstructured":"Lyerly AD. Beyond voluntariness\u2014ethics and incentives for contraception. JAMA Psychiat. 2021;78(10):1069\u201370. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1284.","journal-title":"JAMA Psychiat"},{"key":"760_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106393","author":"A Yermachenko","year":"2020","unstructured":"Yermachenko A, Massari V, Azria E, et al. Unintended pregnancy prevention in women using psychoactive substances: a systematic review. Addict Behav. 2020. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106393.","journal-title":"Addict Behav"},{"key":"760_CR24","unstructured":"Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995."},{"key":"760_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.02.002","author":"DJ Bowen","year":"2009","unstructured":"Bowen DJ, Kreuter M, Spring B, et al. How we design feasibility studies. Am J Prev Med. 2009. https:\/\/doi.org\/10.1016\/j.amepre.2009.02.002.","journal-title":"Am J Prev Med"},{"key":"760_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2017.09.005","author":"C Dehlendorf","year":"2018","unstructured":"Dehlendorf C, Henderson JT, Vittinghoff E, Steinauer J, Hessler D. Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception. 2018. https:\/\/doi.org\/10.1016\/j.contraception.2017.09.005.","journal-title":"Contraception"},{"key":"760_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nn.3945.Dopaminergic","volume":"92","author":"SH Heil","year":"2016","unstructured":"Heil SH, Hand DJ, Sigmon SC, Badger MS, Meyer MC, Higgens ST. Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy. Prev Med. 2016;92:62\u20137. https:\/\/doi.org\/10.1038\/nn.3945.Dopaminergic.","journal-title":"Prev Med"},{"issue":"10","key":"760_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/JAMAPSYCHIATRY.2021.1715","volume":"78","author":"SH Heil","year":"2021","unstructured":"Heil SH, Melbostad HS, Matusiewicz AK, et al. Efficacy and cost-benefit of onsite contraceptive services with and without incentives among women with opioid use disorder at high risk for unintended pregnancy: a randomized clinical trial. JAMA Psychiat. 2021;78(10):1071\u20138. https:\/\/doi.org\/10.1001\/JAMAPSYCHIATRY.2021.1715.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"760_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1353\/hpu.2014.0134","volume":"25","author":"CE Martin","year":"2014","unstructured":"Martin CE, Han JJ, Serio-Chapman C, Chaulk P, Terplan M. Injectable contraceptive continuation among female exotic dancers seeking mobile reproductive health services. J Health Care Poor Underserved. 2014;25(3):1317\u201327. https:\/\/doi.org\/10.1353\/hpu.2014.0134.","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"760_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1353\/hpu.2019.0006","volume":"30","author":"M Nall","year":"2019","unstructured":"Nall M, O\u2019Connor S, Hopper T, Peterson H, Mahajan B. Community women and reproductive autonomy: building an infrastructure for long-acting reversible contraception (LARC) services in a mobile health clinic. J Health Care Poor Underserved. 2019;30(1):47\u201358. https:\/\/doi.org\/10.1353\/hpu.2019.0006.","journal-title":"J Health Care Poor Underserved"},{"key":"760_CR31","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.ijgo.2013.02.005","volume":"121","author":"R Jacobstein","year":"2013","unstructured":"Jacobstein R, Curtis C, Spieler J, Radloff S. Meeting the need for modern contraception: Effective solutions to a pressing global challenge. Int J Gynecol Obstet. 2013;121:S9\u201315. https:\/\/doi.org\/10.1016\/j.ijgo.2013.02.005.","journal-title":"Int J Gynecol Obstet"},{"issue":"10","key":"760_CR32","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2105\/AJPH.2012.300842","volume":"102","author":"E Moore","year":"2012","unstructured":"Moore E, Han J, Serio-Chapman C, Mobley C, Watson C, Terplan M. Contraception and clean needles: Feasibility of combining mobile reproductive health and needle exchange services for female exotic dancers. Am J Public Health. 2012;102(10):1833\u20136. https:\/\/doi.org\/10.2105\/AJPH.2012.300842.","journal-title":"Am J Public Health"},{"key":"760_CR33","doi-asserted-by":"publisher","unstructured":"Curtis KM, Jatlaoui TC, Tepper NK, et al. US selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016. https:\/\/doi.org\/10.15585\/mmwr.rr6504a1.","DOI":"10.15585\/mmwr.rr6504a1"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00760-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T01:04:00Z","timestamp":1678064640000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00760-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00760-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2214464\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written, informed consent prior to enrollment. The study protocol was approved by the Institutional Review Board at Children\u2019s Mercy Kansas City (#1099).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EAH and MKM received investigator-initiated grants from Organon & Co for studies on contraception access. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}